Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD
Clinical trial NCT04680832 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04680832
- Sponsor
- Erasmus Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-01
- Primary completion
- 2025-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.